老板办公室乳摸GIF动态图,色婷婷亚洲一区二区三区,国产全是老熟女太爽了,欧美极度残忍变态另类电影
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2022.10.01
海普瑞：獨(dú)立董事關(guān)于第五屆董事會(huì)第二十二次會(huì)議相關(guān)事項(xiàng)的獨(dú)立意見
2022.10.01
海普瑞：關(guān)于變更H股募集資金使用用途的公告
2022.10.01
海普瑞：關(guān)于召開2022年第二次臨時(shí)股東大會(huì)的通知公告
2022.08.30
海普瑞：獨(dú)立董事關(guān)于控股股東及其他關(guān)聯(lián)方占用公司資金、公司對(duì)外擔(dān)保情況的專項(xiàng)說(shuō)明和...
2022.08.30
海普瑞：半年度非經(jīng)營(yíng)性資金占用及其他關(guān)聯(lián)資金往來(lái)情況匯總表
2022.08.30
海普瑞：2022年半年度報(bào)告摘要
2022.07.21
海普瑞：第五屆董事會(huì)第二十次會(huì)議決議公告
2022.07.21
海普瑞：2021年年度權(quán)益分派實(shí)施公告
2022.07.13
海普瑞：2022年半年度業(yè)績(jī)預(yù)告
2022.06.14
海普瑞：海普瑞2021年年度股東大會(huì)法律意見書
第一頁(yè)
上一頁(yè)
13
14
15
16
17
下一頁(yè)
最后一頁(yè)
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
